EGG Test as a Predictor for an Individual Response to Treatment by Various Bariatric Procedures

Sponsor
Asian Institute of Gastroenterology, India (Other)
Overall Status
Recruiting
CT.gov ID
NCT05731531
Collaborator
(none)
250
1
5
25
10

Study Details

Study Description

Brief Summary

Total body weight loss (TBWL) after bariatric endoscopy (BE) is variable. Gastric emptying may be normal, rapid or delayed in patients with obesity and be a factor in variable BE outcomes. Gastric myoelectrical activity (GMA) reflects gastric pacemaker activity which controls gastric contractions. The non-invasive electrogastrogram(EGG) uses standard electrodes positioned on the abdominal surface to record GMA. The investigators postulate that GMA patterns recorded with EGG will reflect subgroups in regards to stomach electrical physiology in obesity and that these subgroups will be useful in selecting patients for various BE procedures to maximize success of the procedures.

Condition or Disease Intervention/Treatment Phase
  • Device: ELECTROGASTROGRAPHY
N/A

Detailed Description

Electrogastrography is a non-invasive method of recording GMA that is used to diagnose gastric dysrythmias in patients with intractable chronic nausea and vomiting, gastroparesis and gastroesophageal reflux.

Bariatric Techniques: 3 categories 1)restrictive,2) mal absorptive 3)mixed Bariatric endoscopy techniques have emerged as safe and effective treatment that include restrictive endoscopic techniques: Intragastric balloons or endoscopic sleeve gastroplasty(ESG),primary surgery obesity endoluminal (POSE) or Endo-sleeve (GESP or POSE 2.0) procedures; malabsorptive techniques :endoluminal bypass (endobarrier),duodenal mucosa resurfacing; extraction methods (Aspire); electrical stimulation : gastric pacemaker, vagal blockage and other procedures.

Weight loss and long-term maintenance may be conditioned by changes in GMA, as well as by anatomical modifications induced by the bariatric procedure.

Since anatomical modifications of the stomach by the BE procedures are related to weight loss, The purpose is to determine whether different procedures to reduce gastric capacity will result in substantial changes in GMA and in the water load volume ingested. No studies that have studied obese population before and after such BE procedures are available.

Therefore, whether obese patients have the GMA that is similar to those with functional dyspepsia and normal weight . Also, the usefulness of electrogastrography as a new tool to customize choice of Bariatric therapies by determining success or failure based on GMA and WLST results has not been studied. GMA measures the normal or depleted gastric ICCs and the WLST measures gastric capacity, objective measures that may be important to predict success of Bariatric procedures and thus to help with patient selection to maximize efficacy and minimize side effects.

Demonstrate the usefulness of EGG meizuring the GMA by identifying subtypes with the Water Load Satiety Test (WLST) in obese adults to predict individual successful responses to BE treatments: Intragastric Balloon (IGB) placement and Apollo Endoscopic Sleeve Gastroplasty (ESG) method

Study Design

Study Type:
Interventional
Anticipated Enrollment :
250 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Gastric Myoelectric Activity With Water Load Satiety Test as a Predictor of Individual Successful Response to Treatment by Various Bariatric Procedures.
Actual Study Start Date :
Nov 1, 2022
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: Group A

Group of 50 patients who undergo BIG placement

Device: ELECTROGASTROGRAPHY
Electrogastrography as a new tool to customize choice of Bariatric therapies by determining success or failure based on GMA and WLST results has not been studied. GMA measures the normal or depleted gastric ICCs and the WLST measures gastric capacity, objective measures that may be important to predict success of Bariatric procedures and thus to help with patient selection to maximize efficacy and minimize side effects.

Other: Group B

Group of 50 patients who undergo endoscopic sleeve gastroplasty

Device: ELECTROGASTROGRAPHY
Electrogastrography as a new tool to customize choice of Bariatric therapies by determining success or failure based on GMA and WLST results has not been studied. GMA measures the normal or depleted gastric ICCs and the WLST measures gastric capacity, objective measures that may be important to predict success of Bariatric procedures and thus to help with patient selection to maximize efficacy and minimize side effects.

Other: Group C

Group of 50 patients who undergo Surgical sleeve gastrectomy

Device: ELECTROGASTROGRAPHY
Electrogastrography as a new tool to customize choice of Bariatric therapies by determining success or failure based on GMA and WLST results has not been studied. GMA measures the normal or depleted gastric ICCs and the WLST measures gastric capacity, objective measures that may be important to predict success of Bariatric procedures and thus to help with patient selection to maximize efficacy and minimize side effects.

Other: Group D

Group of 50 patients who undergo RYGB

Device: ELECTROGASTROGRAPHY
Electrogastrography as a new tool to customize choice of Bariatric therapies by determining success or failure based on GMA and WLST results has not been studied. GMA measures the normal or depleted gastric ICCs and the WLST measures gastric capacity, objective measures that may be important to predict success of Bariatric procedures and thus to help with patient selection to maximize efficacy and minimize side effects.

Other: Group E

Group of 50 healthy subjects

Device: ELECTROGASTROGRAPHY
Electrogastrography as a new tool to customize choice of Bariatric therapies by determining success or failure based on GMA and WLST results has not been studied. GMA measures the normal or depleted gastric ICCs and the WLST measures gastric capacity, objective measures that may be important to predict success of Bariatric procedures and thus to help with patient selection to maximize efficacy and minimize side effects.

Outcome Measures

Primary Outcome Measures

  1. Changes in EGG parameters like WLST (water load satiety test) GMA Gastric myoelectric activity),Predominant frequency of stomach. [1st or 3rd month of baritaric surgery]

    Pre-intervention EGG parameters and/or changes in EGG parameters (one/three months) after bariatric intervention can predict clinical success at the end the of follow up

  2. Changes in EGG parameters like WLST (water load satiety test) GMA Gastric myoelectric activity),Predominant frequency of stomach at end of the follow up. [18-24 month]

    Pre-intervention EGG parameters and/or changes in EGG parameters (one/three months) after bariatric intervention can predict clinical success at the end the of follow up

Secondary Outcome Measures

  1. EGG as a diagnostic tool to measure WLST (water load satiety test) GMA Gastric myoelectric activity),Predominant frequency of stomach. [12-18 months]

    EGG is a feasible diagnostic tool in obese population with reproducible and predictible results

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Men and women, aged between 18-65 yrs

  • IMC basal ≥ 30 kg/m2

  • Patient undergoing bariatric intervention willing to participate in the study

  • Informed consent (oral and written) for the tests to be carried out.

Exclusion Criteria:
  • Presence of severe cardiac, renal, hepatic, or neurological disease

  • Long term use of medication that alter gastric motility (> 4 weeks)

  • Significant alcohol or opioids or narcotics or tobacco

  • Active malignancy 5.Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 AIG Hospitals Hyderabad Telangana India 500032

Sponsors and Collaborators

  • Asian Institute of Gastroenterology, India

Investigators

  • Study Director: Rakesh Kalpala, MBBS,MD,DM, Senior consultant

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Rakesh Kalapala, Director Endoscopy (center for obesity and metabolic therapy), Asian Institute of Gastroenterology, India
ClinicalTrials.gov Identifier:
NCT05731531
Other Study ID Numbers:
  • AIG/IEC-BH&R32/07.2022-02
First Posted:
Feb 16, 2023
Last Update Posted:
Feb 16, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Rakesh Kalapala, Director Endoscopy (center for obesity and metabolic therapy), Asian Institute of Gastroenterology, India
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 16, 2023